Cargando…

Repurposing Existing Drugs for the Treatment of COVID-19

The rapid global spread and significant mortality associated with the coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection has spurred an urgent race to find effective treatments. Repurposing existing drugs is a particularly attractive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farne, Hugo, Kumar, Kartik, Ritchie, Andrew I., Finney, Lydia J., Johnston, Sebastian L., Singanayagam, Aran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Focused Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640626/ https://www.ncbi.nlm.nih.gov/pubmed/32692580 http://dx.doi.org/10.1513/AnnalsATS.202005-566FR

Ejemplares similares

Why asthma might surprisingly protect against poor outcomes in COVID-19
por: Farne, Hugo, et al.
Publicado: (2020)

Reply
por: Farne, Hugo, et al.
Publicado: (2021)

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
por: Ritchie, Andrew I, et al.
Publicado: (2020)

Repurposing existing drugs for COVID-19: an endocrinology perspective
por: Cadegiani, Flavio A.
Publicado: (2020)

Metagenomic Characterization of the Respiratory Microbiome. A Pièce de Résistance
por: Ritchie, Andrew I., et al.
Publicado: (2020)

Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
por: Finney, Lydia J., et al.
Publicado: (2021)

Repurposing paclitaxel for the treatment of fibrosis: indication discovery for existing drugs
por: Chen, Xiao-Wu, et al.
Publicado: (2015)

Exploring Repurposing Potential of Existing Drugs in the Management of COVID-19 Epidemic: A Critical Review
por: Chakraborty, Debjit, et al.
Publicado: (2020)

Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19
por: Norinder, Ulf, et al.
Publicado: (2020)

Treatments for COVID-19: emerging drugs against the coronavirus
por: Potì, Francesco, et al.
Publicado: (2020)

Quantum OPTICS and deep self-learning on swarm intelligence algorithms for Covid-19 emergency transportation
por: Drias, Habiba, et al.
Publicado: (2022)

Cognitive computing-based COVID-19 detection on Internet of things-enabled edge computing environment
por: Laxmi Lydia, E., et al.
Publicado: (2021)

Drug repurposing for the treatment of COVID-19
por: Kato, Yuri, et al.
Publicado: (2022)

Repurposing drugs for treatment of COVID-19
por: Venkatesan, Priya
Publicado: (2021)

Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study
por: Sankhe, Runali, et al.
Publicado: (2021)

Anti-COVID drugs: repurposing existing drugs or search for new complex entities, strategies and perspectives
por: Pawełczyk, Anna, et al.
Publicado: (2020)

Repurposing existing drugs for monkeypox: applications of virtual screening methods
por: Li, Vladimir, et al.
Publicado: (2023)

Viroinformatics approach to explore the inhibitory mechanism of existing drugs repurposed to fight against COVID-19
por: Bibi, Nousheen, et al.
Publicado: (2020)

IoT-based analysis for controlling & spreading prediction of COVID-19 in Saudi Arabia
por: Sharma, Sunil Kumar, et al.
Publicado: (2021)

Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action()
por: Yousefi, Hassan, et al.
Publicado: (2021)

Repurposed GI Drugs in the Treatment of COVID-19
por: Aguila, Enrik John T., et al.
Publicado: (2020)

Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
por: Raghav, Pawan Kumar, et al.
Publicado: (2023)

Empirical evidence of effects of stringency amid Covid-19 pandemic spread
por: Minu, R. I., et al.
Publicado: (2022)

Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate
por: Mangoni, Arduino A, et al.
Publicado: (2018)

Complement control for COVID-19
por: Bosmann, Markus
Publicado: (2021)

Biserial targeted feature projection based radial kernel regressive deep belief neural learning for covid-19 prediction
por: Subash Chandra Bose, S., et al.
Publicado: (2022)

Leishmania amastigotes as targets for drug screening
por: Monte-Alegre, Adriano, et al.
Publicado: (2006)

A Collaborative Approach for “ReSeq-ing” Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers
por: Schito, Marco, et al.
Publicado: (2015)

Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae
por: Finney, Lydia J, et al.
Publicado: (2014)

Drug repurposing approach to fight COVID-19
por: Singh, Thakur Uttam, et al.
Publicado: (2020)

ELUCNN for explainable COVID-19 diagnosis
por: Wang, Shui-Hua, et al.
Publicado: (2023)

Early diagnosis of COVID-19-affected patients based on X-ray and computed tomography images using deep learning algorithm
por: Dansana, Debabrata, et al.
Publicado: (2020)

Down to a T: The Functional Importance of Lymphopenia in Severe COVID-19
por: Shahridan Faiez, Tasnim, et al.
Publicado: (2022)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Viruses exacerbating chronic pulmonary disease: the role of immune modulation
por: Singanayagam, Aran, et al.
Publicado: (2012)

Repurposing Anti-Cancer Drugs for COVID-19 Treatment
por: Borcherding, Nicholas, et al.
Publicado: (2020)

Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment
por: Martinez, Miguel Angel
Publicado: (2021)

Plitidepsin: a Repurposed Drug for the Treatment of COVID-19
por: Martinez, Miguel Angel
Publicado: (2021)

An Overview of Repurposed Drugs for Potential COVID-19 Treatment
por: Govender, Kamini, et al.
Publicado: (2022)

Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations
por: Calderazzo, Maria Adelaide, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n0imh9c2b6p76urgt86bh5320c